Successful treatment of carbimazole-induced agranulocytosis and severe sepsis with granulocyte macrophage colony stimulating factor.
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced* / Q000628:therapy*; D013956:Antithyroid Agents / Q000009:adverse effects*; D016470:Bacteremia / Q000382:microbiology / Q000628:therapy; D002231:Carbimazole / Q000009:adverse effects*; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007710:Klebsiella Infections / Q000628:therapy*; D007711:Klebsiella pneumoniae; D013971:Thyrotoxicosis / Q000188:drug therapy
D013956:Antithyroid Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002231:Carbimazole